Denying the fact that technology has drastically impacted the lifestyles of humans is unreasonable, rather we all are aware of the evident benefits of technology in the current era. We have witnessed the advantages of technology in our lives and have dealt with the cons successfully. And, now it’s the time to take a step ahead, incorporating technology into Lifesciences and pharma businesses in India.
“Replacing manual efforts with full-fledged automation has benefitted many businesses, lowering their capital investments and boosting revenues.” That’s nothing but automation!
This automation is being achieved through technological implementations. Now, India being the largest supplier of generic drugs in the globe, is ready to inculcate technology as digitalization in pharma sectors. Integrating all the operational channels internally will automate the whole pharma business to attain the next level of technological innovation with digitalization.
Hurdles faced before actuating digitalization in pharma:
With technology in the picture, pharma in India is reaching a higher level of automation with a lot of positive changes but with several unavoidable hurdles. When all the operations in Lifesciences and healthcare industries were being managed using traditional approaches from ages, the digital transformation is going to get tougher for all pharma businesses. But Indian pharmaceuticals have already decided to move forward with new risks, new failures, new successes, and a lot of new learning.
Putting lights on the challenges being faced by pharma businesses to actuate digitalization will help understand the significance of technological transformation to bolster a business.
- It is important to keep patients informed about their diagnosis, medicines, and treatments. Documenting every data of each and every patient manually is a big task with a fair chance of error-making. Instead, automation can collect and process enormous data altogether easily.
- Integrating every quality management system of a pharma business together could be extremely benefitting but difficult and cost-consuming, at the same time. This scares out a lot of businesses to step forward and accept the change.
- Switching a traditionally-run business to a completely digitalized one could be a lot more intimidating as it requires intricate code-run browsers or apps. This reason lets every pharma business have a second thought to actuate digitalization.
Low Code Platforms: A one-stop-shop to all your doubts:
Several pharma companies have already adopted Low Code Platforms to showcase their businesses, but Indian pharma also deserves such amazing options to run digitalization successfully.
Low Code Platforms are developing customized apps keeping all the specific business needs in an account, handling end-to-end business tasks. But before that, let’s discuss the key benefits of a Low Code Platform.
- Introducing out-of-the-box functionalities in the platform will let you pick a particular module or section; Saves a lot of quality time and can use them in other productive growth paths.
- Unique visual modeling features will make the platform ready with minimal coding and programs; Understandable to a technical expert as well as a layperson.
- Accessible to all the devices; Engages with target audiences frequently with no hustle.
- Simple drag and drop features in the platform allow everyone to make desirable changes; Quick and consumes less time.
- Apps come with plug-ins and pre-installed modules; Promotes faster app development
- Scalable feature in the platform; Implement further business growth ideas.
- Develop secured, functional digital platforms; Smooth and quick user access with no fear of cyber-attack.
- Takes permission of the user before making any change in the platform; Consensual agreement to be followed seriously.
- Integrate internal channels one after the other successfully; Products reach to market in lesser time
- Complex operational activities can be processed via digitalization; minimal inclusion of humans and low cost of integration
[box type=”success” align=”” class=”” width=””]When Low Code Platforms are handling a large portion of business in digitalized India during the current pandemic, a recent forecast by Gartner says in 2021 there has been a 22.6% increase in the Low Code technology implementation worldwide from 2020. This is an evident sign that Low Code is going to be a vital part of new-age automation, not only in India but around the globe.[/box]
AmpleLogic holds your back:
Talking about this digital transformation journey, pharma businesses in India are coming across a lot of challenges and implementing various strategic ideas to boost digitalization. Agreeing with the abiding regulation of FDA, 21 CFR Part 11 that says all the manual operations have to be done on digital platforms, AmpleLogic is offering several clients with Low Code Platforms with additive quality management services from the last 10 years. Now, the team is working hard to help pharma businesses understand the efficacy of digitalization and various methods to achieve that technological evolution.
